# NewGait: A Low-Cost Rehabilitation System to Improve Post-Stroke Gait

> **NIH NIH R41** · ELITE ATHLETE PRODUCTS INC · 2022 · $344,843

## Abstract

PROJECT SUMMARY
More than 795,000 individuals suffer from a stroke each year in the United States, making stroke a leading cause
of adult disability in the United States and worldwide. More than half of stroke survivors exhibit reduced
independence and functional mobility due to stroke-related gait impairments. Despite significant advancements
in post-stroke medical care and rehabilitation, current treatments are not successful in optimally restoring gait
function after stroke. It is well established that intense, repetitive task-oriented rehabilitation interventions are
essential for inducing experience-dependent neuroplasticity (defined as the ability of the nervous system to adapt
and optimize its resources through structural and functional changes)—which is a key factor for post-stroke gait
recovery. Accordingly, new therapeutic approaches that rely on specialized gait training devices, such as
treadmills, robotic devices, and exosuits have been developed. However, these devices are typically expensive,
bulky, and not accessible for home use. Moreover, these devices often require uninterrupted power sources,
which is a major barrier for rural communities in developing nations. While some lightweight and “low-cost”
commercial devices exist, they are not often designed based on multi-user feedback and robust biomechanical
data and their clinical utility have not been tested in stroke survivors, thereby limiting usability and effectiveness.
Thus, there is a significant unmet clinical need for an effective, affordable, and portable gait mobility/rehabilitation
device that is accessible for most stroke survivors. Elite Athlete Products (EAP) has designed a wearable gait
rehabilitation system, NewGait, that specifically addresses this clinical need. In this Phase-I STTR, EAP has
assembled an interdisciplinary team to pursue the following specific aims: (1) Identify an optimal NewGait design
based on end-user feedback (design sprints) and musculoskeletal modeling to address the needs of stroke
rehabilitation, (2) Refine the current prototype using data gathered from design sprints and think aloud technique
and perform benchtop testing on the final prototype to validate durability, and (3) Examine short-term gait
adaptations and clinical feasibility in stroke survivors by performing a comparative clinical feasibility study in
stroke survivors to establish the clinical utility of the NewGait device in comparison with two competitive devices
(TheraSuit and TheraTogs). This project combines EAP’s expertise in developing low-cost neurorehabilitation
devices with the clinical, biomechanical, and neuroplasticity expertise of our academic partners at the University
of Michigan and Wayne State University. The successful completion of this Phase-I STTR will lay the foundation
for an evidence-based low-cost gait rehabilitation system that could positively affect the lives of millions of stroke
survivors living across the globe.

## Key facts

- **NIH application ID:** 10611686
- **Project number:** 1R41HD111289-01
- **Recipient organization:** ELITE ATHLETE PRODUCTS INC
- **Principal Investigator:** CHANDRAMOULI KRISHNAN
- **Activity code:** R41 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $344,843
- **Award type:** 1
- **Project period:** 2022-09-22 → 2025-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10611686

## Citation

> US National Institutes of Health, RePORTER application 10611686, NewGait: A Low-Cost Rehabilitation System to Improve Post-Stroke Gait (1R41HD111289-01). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10611686. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*